Articles related to PRECISION MEDICINE

Manifest Technologies is spearheading the use of AI in developing targeted treatments for CNS disorders, aiming to refine patient selection in clinical trials and enhance therapeutic outcomes.

As physicians, understanding the new biomarker legislation is crucial—it not only shapes insurance coverage but also influences clinical decision-making and patient access to precision medicine, potentially leading to more cost-effective and targeted care.

Explore the transformative potential of antibody-drug conjugates (ADCs) in cancer therapy, offering targeted treatments with reduced side effects. Recent approvals and ongoing trials signify a significant shift towards precision medicine in oncology.

This study illuminates the potential of preoperative circulating tumor DNA to redefine the approach to treating high-risk upper tract urothelial carcinoma, offering a nuanced tool for assessing the necessity of neoadjuvant chemotherapy and tailoring patient care.

In an exciting development for schizophrenia research, Dr. Pan Li’s team utilizes CRISPR/Cas9 to explore neuron cell development, focusing on rare gene variants.

In the rapidly evolving field of oncology, artificial intelligence (AI) stands out not just for its potential to revolutionize cancer care, but also for the complex ethical and practical challenges it presents. A recent survey highlights both the enthusiasm and caution among oncologists regarding AI’s integration into clinical practice.